Nivolumab

• Description:

  Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  146 kDa

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  PD-1

• CAS Number:

  946414-94-4